Skip to Main Content

Paper Details

Biosimilar Ranibizumab (SB11) vs Reference Ranibizumab-Diving Deeper for Safety and Efficacy-Reply.
JAMA Ophthalmol
2
2021
Author NameAffiliation
Neil M BresslerJohns Hopkins University School of Medicine
Neil M Bressler
  • 1 - 2

Datasets

Release 1.2